OTCMKTS:MNKKQ

Mallinckrodt News Headlines

$0.27
-0.02 (-6.85 %)
(As of 08/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.27
$0.31
50-Day Range
$0.27
$0.54
52-Week Range
$0.07
$2.37
Volume277,578 shs
Average Volume267,150 shs
Market Capitalization$23.04 million
P/E RatioN/A
Dividend YieldN/A
Beta3.42

Mallinckrodt (OTCMKTS MNKKQ) News Headlines Today

SourceHeadline
Mallinckrodt (OTCMKTS:MNKKQ) Trading Up 2.8%Mallinckrodt (OTCMKTS:MNKKQ) Trading Up 2.8%
americanbankingnews.com - July 14 at 12:28 AM
If You Think You Or A Deceased Loved One Was Harmed By Opioids Like Hydrocodone, Oxycodone, Codeine Or Roxicodone, Or If You Care For A Child Exposed To These Opioids In The Womb, You Can Vote On The Mallinckrodt Bankruptcy Plan. - Yahoo FinanceIf You Think You Or A Deceased Loved One Was Harmed By Opioids Like Hydrocodone, Oxycodone, Codeine Or Roxicodone, Or If You Care For A Child Exposed To These Opioids In The Womb, You Can Vote On The Mallinckrodt Bankruptcy Plan. - Yahoo Finance
finance.yahoo.com - July 9 at 11:27 AM
Mandos, LLC Completes Acquisition of Adrabetadex from Mallinckrodt Pharmaceuticals - Business WireMandos, LLC Completes Acquisition of Adrabetadex from Mallinckrodt Pharmaceuticals - Business Wire
businesswire.com - July 1 at 7:32 PM
Mallinckrodts Acthar gel included in ERS treatment guidelines for pulmonary sarcoidosis - Seeking AlphaMallinckrodt's Acthar gel included in ERS treatment guidelines for pulmonary sarcoidosis - Seeking Alpha
seekingalpha.com - July 1 at 9:21 AM
Mallinckrodt Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection) in New European Respiratory Society (ERS) Treatment Guidelines for Patients with Pulmonary SarcoidosisMallinckrodt Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection) in New European Respiratory Society (ERS) Treatment Guidelines for Patients with Pulmonary Sarcoidosis
finance.yahoo.com - July 1 at 9:21 AM
FDA approves Mallinckrodt product StrataGraft for skin burns - Seeking AlphaFDA approves Mallinckrodt product StrataGraft for skin burns - Seeking Alpha
seekingalpha.com - June 15 at 5:27 PM
Mallinckrodt opioid claimants call for more reorg plan disclosures - ReutersMallinckrodt opioid claimants call for more reorg plan disclosures - Reuters
reuters.com - May 24 at 6:01 PM
Legal Week Ahead in Products Liability: May 24, 2021 - ReutersLegal Week Ahead in Products Liability: May 24, 2021 - Reuters
reuters.com - May 22 at 12:45 AM
Beyond Air® Strengthens Commercial Leadership Team with - GlobeNewswireBeyond Air® Strengthens Commercial Leadership Team with - GlobeNewswire
globenewswire.com - May 20 at 9:03 AM
ITM to Host Virtual Symposium on "New Approaches for Targeted Radionuclide Therapy in Precision Oncology" with Key Opinion Leaders on Friday, June 4th, 2021 in Parallel to 2021 ASCO Annual Meeting - Yahoo FinanceITM to Host Virtual Symposium on "New Approaches for Targeted Radionuclide Therapy in Precision Oncology" with Key Opinion Leaders on Friday, June 4th, 2021 in Parallel to 2021 ASCO Annual Meeting - Yahoo Finance
finance.yahoo.com - May 20 at 9:03 AM
Mallinckrodt Presents Data Evaluating Acthar® Gel (Repository Corticotropin Injection) for the Treatment of Severe Keratitis at the Association for Research in Vision and Ophthalmology (ARVO) Annual MeetingMallinckrodt Presents Data Evaluating Acthar® Gel (Repository Corticotropin Injection) for the Treatment of Severe Keratitis at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
finance.yahoo.com - May 3 at 9:52 AM
Mallinckrodt Presents Data Evaluating INOmax® (Nitric Oxide) Gas, for Inhalation in a Phase 4 Observational Registry in Neonates with Pulmonary Hypertension at the Pediatric Academic Societies (PAS) 2021 Virtual MeetingMallinckrodt Presents Data Evaluating INOmax® (Nitric Oxide) Gas, for Inhalation in a Phase 4 Observational Registry in Neonates with Pulmonary Hypertension at the Pediatric Academic Societies (PAS) 2021 Virtual Meeting
finance.yahoo.com - April 30 at 12:57 PM
ANI Pharmaceuticals, Inc. -- Moodys assigns first-time B2 CFR to ANI Pharmaceuticals; outlook stableANI Pharmaceuticals, Inc. -- Moody's assigns first-time B2 CFR to ANI Pharmaceuticals; outlook stable
finance.yahoo.com - April 27 at 5:07 PM
Global Radiopharmaceutical Market Size and Share 2021 | Industry Analysis By Trends, Key Findings, Future Demands, Growth Factors, Emerging Technologies, Leading Players Updates and Forecast Till 2026 - BenzingaGlobal Radiopharmaceutical Market Size and Share 2021 | Industry Analysis By Trends, Key Findings, Future Demands, Growth Factors, Emerging Technologies, Leading Players Updates and Forecast Till 2026 - Benzinga
benzinga.com - April 25 at 12:22 PM
Bankruptcy watchdog opposes Mallinckrodt bonus plan for execs - ReutersBankruptcy watchdog opposes Mallinckrodt bonus plan for execs - Reuters
reuters.com - March 23 at 11:17 PM
IN BRIEF: Acthar price-fixing plaintiffs want Illinois MDL - ReutersIN BRIEF: Acthar price-fixing plaintiffs want Illinois MDL - Reuters
reuters.com - March 16 at 1:02 AM
Mallinckrodt Announces New England Journal of Medicine Publication of Results from its Phase 3 CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1)Mallinckrodt Announces New England Journal of Medicine Publication of Results from its Phase 3 CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1)
finance.yahoo.com - March 4 at 7:04 AM
Silence Therapeutics and Mallinckrodt Initiate Work on Third Target as Part of Ongoing RNAi Research Collaboration for Complement-Mediated Diseases - GlobeNewswireSilence Therapeutics and Mallinckrodt Initiate Work on Third Target as Part of Ongoing RNAi Research Collaboration for Complement-Mediated Diseases - GlobeNewswire
globenewswire.com - February 26 at 7:40 AM
Whats in Store for Mallinckrodt (MNKKQ)This Earnings Season? - Yahoo FinanceWhat's in Store for Mallinckrodt (MNKKQ)This Earnings Season? - Yahoo Finance
finance.yahoo.com - February 12 at 12:37 PM
Mallinckrodt Provides Regulatory Update on StrataGraft®Mallinckrodt Provides Regulatory Update on StrataGraft®
finance.yahoo.com - February 12 at 7:36 AM
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More - BenzingaThe Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More - Benzinga
benzinga.com - January 30 at 11:51 PM
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More - Yahoo FinanceThe Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More - Yahoo Finance
finance.yahoo.com - January 30 at 6:50 PM
Mallinckrodt Earns Top Marks in Human Rights Campaigns 2021 Corporate Equality Index - Yahoo FinanceMallinckrodt Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index - Yahoo Finance
finance.yahoo.com - January 29 at 5:05 PM
When Drug Development for Rare Disease Hit Setback, Parents Were Stung - The Wall Street JournalWhen Drug Development for Rare Disease Hit Setback, Parents Were Stung - The Wall Street Journal
wsj.com - January 28 at 12:44 PM
Mallinckrodt (MNKKQ) Gains As Market Dips: What You Should Know - Yahoo FinanceMallinckrodt (MNKKQ) Gains As Market Dips: What You Should Know - Yahoo Finance
finance.yahoo.com - January 26 at 11:00 PM
Mallinckrodt (MNKKQ) Gains As Market Dips: What You Should KnowMallinckrodt (MNKKQ) Gains As Market Dips: What You Should Know
finance.yahoo.com - January 26 at 11:00 PM
The Buxton Helmsley Group Announces Major Shareholder Backing to Call Mallinckrodt Meeting of Shareholders, Realign Board and Management with Shareholder Interests, Renegotiate Restructuring PlanThe Buxton Helmsley Group Announces Major Shareholder Backing to Call Mallinckrodt Meeting of Shareholders, Realign Board and Management with Shareholder Interests, Renegotiate Restructuring Plan
finance.yahoo.com - January 20 at 6:44 PM
Judge Approves Mallinckrodt to Reimburse Creditor Fees - The Wall Street JournalJudge Approves Mallinckrodt to Reimburse Creditor Fees - The Wall Street Journal
wsj.com - January 20 at 6:54 AM
George Mallinckrodt, Former Chairman of Schroders, Dies at 90 - BloombergGeorge Mallinckrodt, Former Chairman of Schroders, Dies at 90 - Bloomberg
bloomberg.com - January 19 at 3:52 PM
Top Ranked Value Stocks to Buy for December 21stTop Ranked Value Stocks to Buy for December 21st
finance.yahoo.com - December 21 at 1:10 PM
BZI-ITBZI-IT
benzinga.com - December 18 at 7:33 PM
Insider Sells Mallinckrodts StockInsider Sells Mallinckrodt's Stock
benzinga.com - December 18 at 2:32 PM
Insider Sells Mallinckrodts  StockInsider Sells Mallinckrodt's Stock
finance.yahoo.com - December 18 at 2:32 PM
Mallinckrodt retrospective study on use of nitric oxide in COVID-19Mallinckrodt retrospective study on use of nitric oxide in COVID-19
seekingalpha.com - November 10 at 10:06 AM
Mallinckrodt launches retrospective study on use of nitric oxide in COVID-19Mallinckrodt launches retrospective study on use of nitric oxide in COVID-19
seekingalpha.com - November 10 at 10:06 AM
Mallinckrodt Initiates Retrospective Study of the Use of Inhaled Nitric Oxide in COVID-19 PatientsMallinckrodt Initiates Retrospective Study of the Use of Inhaled Nitric Oxide in COVID-19 Patients
finance.yahoo.com - November 10 at 10:06 AM
Escalating Debt Brawls Add to Headache for Distressed CompaniesEscalating Debt Brawls Add to Headache for Distressed Companies
finance.yahoo.com - October 28 at 6:23 PM
This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.